{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T10:29:22Z","timestamp":1777544962659,"version":"3.51.4"},"reference-count":44,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007750","name":"National Cheng Kung University","doi-asserted-by":"publisher","award":["A-ER-110-421"],"award-info":[{"award-number":["A-ER-110-421"]}],"id":[{"id":"10.13039\/501100007750","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004844","name":"National Cheng Kung University Hospital","doi-asserted-by":"publisher","award":["NCKUH-11404007"],"award-info":[{"award-number":["NCKUH-11404007"]}],"id":[{"id":"10.13039\/501100004844","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["114-2314-B-006 \\u2212044"],"award-info":[{"award-number":["114-2314-B-006 \\u2212044"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["112-2314-B-006 \\u2212047 -MY2"],"award-info":[{"award-number":["112-2314-B-006 \\u2212047 -MY2"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.clinthera.2025.09.014","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T04:57:13Z","timestamp":1759813033000},"page":"1130-1136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Differential Effects of Anti-Seizure Medications on Sarcopenia in Patients With Epilepsy"],"prefix":"10.1016","volume":"47","author":[{"given":"Yu-Shiue","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Chi","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huai-Chun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huai-Ying Ingrid","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3335-2187","authenticated-orcid":false,"given":"Chin-Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2025.09.014_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2022.106917","article-title":"Prevalence of comorbidities, and affective disorders in epilepsy: a latent class analysis approach","volume":"182","author":"Rainer","year":"2022","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.clinthera.2025.09.014_bib0002","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/epi.16856","article-title":"The road to a World Health Organization global action plan on epilepsy and other neurological disorders","volume":"62","author":"Guekht","year":"2021","journal-title":"Epilepsia"},{"key":"10.1016\/j.clinthera.2025.09.014_bib0003","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jamda.2019.12.012","article-title":"Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment","volume":"21","author":"Chen","year":"2020","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.clinthera.2025.09.014_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00223-021-00898-1","article-title":"Sarcopenia in chronic kidney disease: a scoping review of prevalence, risk factors, association with outcomes, and treatment","volume":"110","author":"Chatzipetrou","year":"2022","journal-title":"Calcif tissue int"},{"key":"10.1016\/j.clinthera.2025.09.014_bib0005","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3390\/nu13020659","article-title":"Compound sarcopenia in hospitalized patients with cirrhosis worsens outcomes with increasing age","volume":"13","author":"Welch","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.clinthera.2025.09.014_bib0006","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.850964","article-title":"Pathogenesis of sarcopenia in chronic obstructive pulmonary disease","volume":"13","author":"Ma","year":"2022","journal-title":"Front Physiol"},{"key":"10.1016\/j.clinthera.2025.09.014_bib0007","doi-asserted-by":"crossref","first-page":"786","DOI":"10.3390\/cancers14030786","article-title":"Effect of exercise on sarcopenia among cancer survivors: a systematic review","volume":"14","author":"Cao","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.clinthera.2025.09.014_bib0008","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s13760-020-01488-y","article-title":"Recommendations for the treatment of epilepsy in adult and pediatric patients in Belgium: 2020 update","volume":"121","author":"Boon","year":"2021","journal-title":"Acta Neurol Belg"},{"key":"10.1016\/j.clinthera.2025.09.014_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2022.101755","article-title":"Impaired bone health as a co-morbidity of epilepsy","volume":"36","author":"Andersen","year":"2022","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.clinthera.2025.09.014_bib0010","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1001\/jamaneurol.2021.3424","article-title":"Association of enzyme-inducing antiseizure drug use with long-term cardiovascular disease","volume":"78","author":"Josephson","year":"2021","journal-title":"JAMA neurol"},{"key":"10.1016\/j.clinthera.2025.09.014_bib0011","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1212\/WNL.96.15_supplement.1966","article-title":"Bone density screening in epilepsy patients (1966)","volume":"96","author":"Montes-Rivera","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.clinthera.2025.09.014_bib0012","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/epi.13670","article-title":"Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"Fisher","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.clinthera.2025.09.014_bib0013","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"Von Elm","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2025.09.014_bib0014","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1528-1167.2009.02235.x","article-title":"Should enzyme-inducing antiepileptic drugs be considered first-line agents?","volume":"50","author":"Mintzer","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.clinthera.2025.09.014_bib0015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1528-1167.2012.03671.x","article-title":"Enzyme induction with antiepileptic drugs: cause for concern?","volume":"54","author":"Brodie","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.clinthera.2025.09.014_bib0016","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1001\/jamaneurol.2023.1580","article-title":"Independent associations of incident epilepsy and enzyme-inducing and non-enzyme-inducing antiseizure medications with the development of osteoporosis","volume":"80","author":"Josephson","year":"2023","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.clinthera.2025.09.014_bib0017","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/epi.17822","article-title":"The extent of cytochrome P450 3A induction by antiseizure medications: a systematic review and network meta-analysis","volume":"65","author":"Cohen","year":"2024","journal-title":"Epilepsia"},{"key":"10.1016\/j.clinthera.2025.09.014_bib0018","doi-asserted-by":"crossref","first-page":"367","DOI":"10.4103\/aian.AIAN_216_17","article-title":"Bone health in patients with epilepsy: a community-based pilot nested case\u2013control study","volume":"20","author":"Singla","year":"2017","journal-title":"Ann Indian Acad Neurol"},{"key":"10.1016\/j.clinthera.2025.09.014_bib0019","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.seizure.2025.01.003","article-title":"Prevalence of and risk factors for sarcopenia in patients with epilepsy","volume":"125","author":"Chen","year":"2025","journal-title":"Seizure"},{"key":"10.1016\/j.clinthera.2025.09.014_bib0020","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1528-1167.2012.03671.x","article-title":"Enzyme induction with antiepileptic drugs: cause for concern?","volume":"54","author":"Brodie","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.clinthera.2025.09.014_bib0021","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1528-1167.2009.02235.x","article-title":"Should enzyme-inducing antiepileptic drugs be considered first-line agents?","volume":"50","author":"Mintzer","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.clinthera.2025.09.014_bib0022","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1111\/j.0013-9580.2004.18804.x","article-title":"Fracture risk associated with use of antiepileptic drugs","volume":"45","author":"Vestergaard","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.clinthera.2025.09.014_bib0023","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bone.2008.03.002","article-title":"Predictors of bone density in ambulatory patients on antiepileptic drugs","volume":"43","author":"El-Hajj Fuleihan","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.clinthera.2025.09.014_bib0024","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s10072-017-2993-7","article-title":"Phenytoin: neuroprotection or neurotoxicity?","volume":"38","author":"Keppel Hesselink","year":"2017","journal-title":"Neurol Sci"},{"key":"10.1016\/j.clinthera.2025.09.014_bib0025","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00774-019-01048-2","article-title":"Updated concept of sarcopenia based on muscle-bone relationship","volume":"38","author":"Yakabe","year":"2020","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.clinthera.2025.09.014_bib0026","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.nutos.2023.11.001","article-title":"Prevalence of and risk factors for pre-sarcopenia among healthcare professionals","volume":"52","author":"Chen","year":"2023","journal-title":"Clin Nutr Open Sci"},{"key":"10.1016\/j.clinthera.2025.09.014_bib0027","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.seizure.2025.01.003","article-title":"Prevalence of and risk factors for sarcopenia in patients with epilepsy","volume":"125","author":"Chen","year":"2025","journal-title":"Seizure"},{"key":"10.1016\/j.clinthera.2025.09.014_bib0028","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1136\/jnnp.45.7.620","article-title":"Anticonvulsant peripheral neuropathy: a clinical and electrophysiological study of patients on single drug treatment with phenytoin, carbamazepine or barbiturates","volume":"45","author":"Shorvon","year":"1982","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.clinthera.2025.09.014_bib0029","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(02)11203-7","article-title":"Clinical importance of the cytochromes P450","volume":"360","author":"Nebert","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2025.09.014_bib0030","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1212\/01.wnl.0000178988.78039.40","article-title":"Differential effects of antiepileptic drugs on sexual function and hormones in men with epilepsy","volume":"65","author":"Herzog","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.clinthera.2025.09.014_bib0031","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1111\/j.1528-1167.2006.00506.x","article-title":"Effects of carbamazepine and oxcarbazepine on the reproductive endocrine function in women with epilepsy","volume":"47","author":"L\u00f6fgren","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.clinthera.2025.09.014_bib0032","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1528-1167.2008.01966.x","article-title":"Changes in sex steroid levels in women with epilepsy on treatment: relationship with antiepileptic therapies and seizure frequency","volume":"50","author":"Galimberti","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.clinthera.2025.09.014_bib0033","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/agm2.12080","article-title":"Osteosarcopenia: a case of geroscience","volume":"2","author":"Kirk","year":"2019","journal-title":"Aging Med"},{"key":"10.1016\/j.clinthera.2025.09.014_bib0034","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1007\/s00198-017-4151-8","article-title":"Osteosarcopenia: where bone, muscle, and fat collide","volume":"28","author":"Hirschfeld","year":"2017","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.clinthera.2025.09.014_bib0035","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","article-title":"Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells","volume":"20","author":"G\u00f6ttlicher","year":"2001","journal-title":"EMBO J"},{"key":"10.1016\/j.clinthera.2025.09.014_bib0036","doi-asserted-by":"crossref","first-page":"38","DOI":"10.53350\/pjmhs2216738","article-title":"Frequency of vitamin D deficiency in patients of epilepsy on valproate sodium","volume":"16","author":"Magsi","year":"2022","journal-title":"Pak J Med Health Sci"},{"key":"10.1016\/j.clinthera.2025.09.014_bib0037","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.phrs.2003.11.011","article-title":"The effect of valproate on bone mineral density in adult epileptic patients","volume":"50","author":"Boluk","year":"2004","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.clinthera.2025.09.014_bib0038","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1007\/s12603-021-1682-7","article-title":"25OH vitamin D is no associated with muscle function loss in adults and elderly patients undergoing hemodialysis","volume":"25","author":"Marini","year":"2021","journal-title":"J Nutr Health Aging"},{"key":"10.1016\/j.clinthera.2025.09.014_bib0039","article-title":"No independent association between dietary calcium\/vitamin D and appendicular lean mass index in middle-aged women: NHANES cross-sectional analysis (2011-2018)","volume":"15","author":"Lai","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.clinthera.2025.09.014_bib0040","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/s41598-025-85468-3","article-title":"Age but not vitamin D is related to sarcopenia in vitamin D sufficient male elderly in rural China","volume":"15","author":"Mi","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.clinthera.2025.09.014_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2021.106619","article-title":"The effects of antiepileptic drugs on bone health: a systematic review","volume":"173","author":"Griepp","year":"2021","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.clinthera.2025.09.014_bib0042","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1528-1167.2008.01561.x","article-title":"Antiepileptic drugs\u2013best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies","volume":"49","author":"Patsalos","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.clinthera.2025.09.014_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2022.101755","article-title":"Impaired bone health as a co-morbidity of epilepsy","volume":"36","author":"Andersen","year":"2022","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.clinthera.2025.09.014_bib0044","doi-asserted-by":"crossref","first-page":"16e31","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291825003248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291825003248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T17:32:00Z","timestamp":1777397520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291825003248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":44,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0149291825003248"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2025.09.014","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential Effects of Anti-Seizure Medications on Sarcopenia in Patients With Epilepsy","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2025.09.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}